According to the report, the global cardiac rehabilitation market was estimated at $1.97 billion in 2021, and is anticipated to hit $3.24 billion by 2031, registering a CAGR of 5.1% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chain, competitive scenario, and regional landscape. The market study is exclusively meant to help the readers with a complete valuation of industry analysis and trends.
Increase in the prevalence of cardiovascular diseases along with surge in demand for minimally invasive surgeries drives the growth of the global cardiac rehabilitation market. Moreover, rise in the incidence of diabetes and obesity which are known to cause heart diseases has led to the development of new preventive equipment by the large number of key players, which has supplemented the market growth even more. At the same time, the growing number of new product launches by the frontrunners in the sector has created multiple opportunities in the industry.
The treadmill segment to dominate by 2031-
Based on product, the treadmill segment held around one-fourth of the global cardiac rehabilitation market revenue in 2021, and is expected to lead the trail by 2031, due to higher demand for this equipment during conducting cardiac rehabilitation programs across various settings. The blood pressure monitor, nevertheless, would manifest the fastest CAGR of 8.2% from 2022 to 2031.
The coronary artery disease segment to maintain the lion's share-
Based on disease type, the coronary artery disease segment generated the major share in 2021, holding nearly two-fifths of the global cardiac rehabilitation market, and is projected to dominate throughout the forecast period. This is due to increasing number of patients with coronary artery diseases across the globe. The Percutaneous segment, simultaneously, would cite the fastest CAGR of 7.1% by 2031. This is owing to surge in demand for percutaneous coronary intervention to treat heart-related disease.
The rehab centers segment to rule the roost-
By end user, the rehab centers segment contributed to nearly two-fifths of the global cardiac rehabilitation market share in 2021, and is expected to retain its dominance by 2031. Increase in number of rehab centers providing rehabilitation therapies across both the developed and developing countries fuels the segment growth. The others segment, on the other hand, is expected to exhibit the fastest CAGR of 7.1% from 2022 to 2031. This is attributed to rise in adoption of cardiac rehabilitation therapies across home care and other long-term care settings.
North America garnered the major share in 2021-
Based on region, North America held the major share in 2021, generating more than two-fifths of the global cardiac rehabilitation market. Robust infrastructure provided for research activities and the presence of key players across the region drive the market growth. The presence of the large automotive and construction industries fuels the market growth. Asia-Pacific, simultaneously, would garner the fastest CAGR of 6.9% by 2031. Growing adoption of novel technologies, increasing focus on reducing the burden of heart diseases, rise in R&D activities for new product launches, and surge in investments in the healthcare sector propel the market growth altogether.
Key players in the industry-
The report analyzes these key players in the global cardiac rehabilitation market. These players have incorporated various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in assessing the operating segments, their business performance & product portfolio, and so on.
Key Benefits for Stakeholders